500x330CRCJeffGrossCarolina Retina Center was founded by Jeffrey G. Gross, MD in 1992 and was the first private vitreoretinal practice in Central South Carolina. Prior to that time patients with retinal diseases were sent to university clinics and multispecialty offices as far away as Georgia and North Carolina. There was an unmet need in Columbia, and the surrounding cities and counties, for state-of-the-art diagnostics and treatments. Carolina Retina Center established a center of excellence and currently receives referrals from over one hundred ophthalmologists, optometrists, and primary care physicians. Some patients, before coming to Carolina Retina Center, traveled as far as to Johns Hopkins University in Baltimore for consultations only to be told that they could receive equivalent care with us.

Our core principle has been to provide exceptional care in a compassionate setting. Our patients come first. We recognize that many patients require urgent appointments so we make every effort to schedule appointments as quickly as possible, even the same day if necessary. Carolina Retina Center has two board certified vitreoretinal specialists who have completed a demanding two year fellowship: Dr. Jeffrey Gross, and Dr. Barron Fishburne. Four strategically placed offices around the state provide easy access from locations up to two hours from Columbia. We have 24 hour call for emergencies.

Our philosophy is to support our referring physicians and work in cooperation. We focus our care only on disorders of the vitreous and retina and we are the best in the diagnoses and management of common and challenging diseases. We have earned the reputation for the place to go for excellent care. Our surgical outcomes are without rival. We believe in fixing it correctly the first time.

Not only do we excel in the clinical care of the patient we also have earned a superior reputation for clinical research. Our practice has participated in trials investigating new drugs and treatments for diabetic retinopathy, age-related macular degeneration, central and branch retinal vein occlusion, uveitis and retinitis. We are constantly adding new studies and recruiting patients to take advantage of breakthrough therapies. Our research center has certified coordinators and imaging specialists. Our work in diabetic retinopathy, macular degeneration, and surgical diseases has been published in major journals and led to changes in the national preferred practice patterns. Some of this research has changed where and how we treat certain conditions. The success of anti-vascular endothelial growth factor (anti-VEGF) injections allows for in office care of many diseases that previously were not treatable.

Carolina Retina Center is focused on sight.